Why Incyte Corporation (INCY) stock moved
Incyte Corporation (INCY) shares fell 0.1% to $116.80 as of October 29, 2026, a slight decline from the prior close of $116.87. BestStocks flagged the session as a major change for INCY. The move is tied to company news. Below, we break down what changed for INCY, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
Company News
Incyte presented new clinical data on its gastrointestinal cancer pipeline at ESMO 2026 conference. New efficacy or safety data could strengthen INCY's competitive position in GI cancers and support pipeline advancement.
What it means for Incyte Corporation investors
For Incyte Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Earnings beat — stock sold off (sell-the-news reaction); Positive price momentum. Weighing against that: Negative session, down 0.1%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $136.53, implying +16.9% upside from $116.80. BestStocks rates the overall signal quality low (40/100). With earnings roughly 103 days out, the next report is the most likely near-term test of the move.
INCY price reaction
INCY last traded at $116.80, down $0.07 (-0.06%) from the previous close of $116.87. The session traded on 1.8× average volume (above avg), so the move carried above-average conviction. Over the past month the stock has ranged between $108.62 and $124.82, and it currently sits about 50% of the way up that band.
Bullish and bearish analyst opinions on Incyte Corporation (INCY)
The consensus analyst price target on Incyte Corporation (INCY) is $136.53, 16.9% above the recent $116.80. Over the past 90 days analysts logged 0 upgrades, 14 maintains, and 0 downgrades. Here is how the bullish and bearish cases on INCY line up.
The bullish case
- Wall Street's consensus price target of $136.53 implies +16.9% upside from $116.80.
- The Street's most bullish target is $157.00 (+34.4%).
- Earnings beat — stock sold off (sell-the-news reaction).
- Positive price momentum.
The bearish case
- The most bearish analyst target is $104.00 (-11.0%).
- Negative session, down 0.1%.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 29, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for INCY
In-depth INCY event analyses
Frequently asked questions about INCY
Why did Incyte Corporation (INCY) stock move?
INCY fell 0.1% to $116.80. The move is associated with company news.
How much did INCY stock fall?
INCY lost 0.06% ($0.07) versus the prior close of $116.87, last trading at $116.80 on 1.8× average volume.
When is Incyte Corporation's next earnings date?
INCY's next earnings report is estimated for 2027-02-09 — about 103 days away.
What is the analyst price target for INCY?
The consensus analyst price target for INCY is $136.53, about 16.9% above the current $116.80. Over the past 90 days, analysts recorded 0 upgrades, 14 maintains, and 0 downgrades.
How BestStocks tracks INCY
This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for INCY, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 29, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.